Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., received notices for allowance for two patents. The first is directed to a class of compounds combining elements of diketopiperazines and methylphenidate derives, while the second is directed to derivatives of methylphenidate (Ritalin).